These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9163583)

  • 1. Chronic transfusion programmes in sickle cell disease: problem or panacea?
    Serjeant GR
    Br J Haematol; 1997 May; 97(2):253-5. PubMed ID: 9163583
    [No Abstract]   [Full Text] [Related]  

  • 2. Techniques for blood administration in sickle cell patients.
    Eckman JR
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):23-9. PubMed ID: 11206958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia.
    Buchanan GR; Bowman WP; Smith SJ
    J Pediatr; 1983 Dec; 103(6):921-3. PubMed ID: 6644427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
    Okusanya BO; Oladapo OT
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010378. PubMed ID: 24297507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy.
    Jackson B; Fasano R; Roback J
    Transfus Med Rev; 2018 Oct; 32(4):220-224. PubMed ID: 30029813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusion in sickle cell anemia].
    Bachir D; Bonnet-Gajdos M; Galacteros F
    Presse Med; 1990 Oct; 19(35):1627-31. PubMed ID: 2147256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.
    McLaughlin JF; Ballas SK
    Transfusion; 2016 May; 56(5):1014-21. PubMed ID: 26593779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the NIH: Improved methods of blood transfusion for patients with sickle cell anemia.
    JAMA; 1983 Feb; 249(6):699-700. PubMed ID: 6823022
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfusion Therapy in Children With Sickle Cell Disease.
    Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of transfusion therapy in the treatment of sickle cell disease.
    Miller C
    J Intraven Nurs; 1994; 17(2):70-3. PubMed ID: 8064491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion practice for patients with sickle cell disease.
    Reed WF; Vichinsky EP
    Curr Opin Hematol; 1999 Nov; 6(6):432-6. PubMed ID: 10546799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion management in sickle cell disease.
    Wanko SO; Telen MJ
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):803-26, v-vi. PubMed ID: 16214645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion in sickle cell anemia revisited.
    Koo AP
    Transfusion; 2009 May; 49(5):821-3. PubMed ID: 19437612
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive Splenic Infarction in a Child With Sickle Cell Disease on Chronic Transfusion Therapy.
    Pereda MA; Isaac J; Zhang Y; Jayakumar R; Gupta R; Miller ST
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):e79-e82. PubMed ID: 30499910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transfusion phenotype matching for sickle cell disease patients.
    Afenyi-Annan A; Brecher ME
    Transfusion; 2004 Apr; 44(4):619-20. PubMed ID: 15043582
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of transfusion practices in sickle cell disease in Senegal: cohort study of 1078 patients with sickle cell disease.
    Seck M; Tall A; Faye BF; Bah DS; Guéye Y; Sall A; Touré AO; Diop S
    Med Sante Trop; 2017 Nov; 27(4):402-406. PubMed ID: 29313508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic case study. Post-transfusional reticuloendothelial system iron overload of sickle cell disease, secondary hemochromatosis.
    Hennemeyer C; Sundaram M
    Orthopedics; 2000 Apr; 23(4):303, 398-400. PubMed ID: 10791578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.